researchers said today that a new drug dramatically slows the progression of parkinson's disease and should be used in all patients with early stages of the debilitating nerve illness based on preliminary results of a large-scale study the researchers said the drug deprenyl delays the onset of advanced symptoms of parkinson's by at least one year and is remarkably safe parkinson's is a degenerative disease of the nervous system that mostly strikes people over 40 about 500,000 americans suffer from it i strongly recommend that all patients with early parkinson's be considered for this therapy said ira shulson a neurologist at the university of rochester in rochester n y and the study's principal investigator